# Koto Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/koto-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 97 |
| Citations | 37,216 |
| City | Tokyo |
| Country | JP |
| Description | Koto Hospital is a research organisation in Tokyo, JP. OpenAlex records 1,220 works and 37,216 citations for it. 380 researchers list it as their most recent affiliation. |
| Homepage | http://www.koto-hospital.or.jp/ |
| OpenAlex ID | https://openalex.org/I4210146506 |
| Researchers | 380 |
| ROR ID | https://ror.org/045rd3583 |
| Type | healthcare |
| Works | 1,220 |

## University papers

- [Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis](https://scholariq.org/papers/effects-of-eicosapentaenoic-acid-on-major-coronary-events-in/)
- [Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage](https://scholariq.org/papers/increased-microrna-1-and-microrna-133a-levels-in-serum-of-patients-with/)
- [Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation](https://scholariq.org/papers/antiplatelet-therapy-and-stent-thrombosis-after-sirolimus-eluting-stent/)
- [Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice](https://scholariq.org/papers/dysfunction-of-fibroblasts-of-extrarenal-origin-underlies-renal-fibrosis-and/)
- [Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)](https://scholariq.org/papers/effects-of-epa-on-coronary-artery-disease-in-hypercholesterolemic-patients-with/)

## University top topics

Showing 8 of 25.

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)
- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dysphagia Assessment and Management](https://scholariq.org/topics/dysphagia-assessment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.